Sep 07, 2023 / 01:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Vivoryon Therapeutics Half Year Results 2023 Earnings Call and Webcast. (Operator Instructions) Please note that today's conference is being recorded.
I would now like to turn the conference over to your first speaker, Anne Doering, Chief Strategy and Investor Relations Officer. Please go ahead.
Anne Doering - Vivoryon Therapeutics N.V. - Chief Strategy & IR Officer and Member of the Management Board
Thank you, Rod. Good afternoon, and thank you for joining us today for Vivoryon's conference call to discuss the company's first half 2023 results and operational progress. This morning, Vivoryon issued a press release reporting its first half 2023 results, which is posted on the company's website at www.vivoryon.com.
On the call with me today are Vivoryon's new Chief Executive Officer, Frank Weber; and Florian Schmid, our Chief Financial Officer. Also with us on today's call and available for questions is Michael Schaeffer,
Half Year 2023 Vivoryon Therapeutics NV Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot